6640--FY26| Thyroid Cancer Molecular Test| Orlando VA & San Juan New Requirement

The Orlando VA Healthcare System and Caribbean VA Healthcare System intends to solicit and award an acquisition for Thyroid Cancer Molecular Test. The performance period for this contract will be date of award to date of completion. The Primary North American Industry Classification System (NAICS) for this acquisition is 621511, with a related small business size standard of $41.5 Million. The proposed action is for Firm-Fixed Price (FFP) requirement contract, which will be advertised as a set aside to service-disabled veteran owned small business on or about 15 December 2025, via sam.gov website. The solicitation and incorporated provisions and clauses are those in effect through Federal Acquisition Circular 2025-06 10/01/2025. It is the responsibility of the quoter to review the web page for notice of amendments, updates, or changes to the solicitation. No hard copies will be mailed. To be eligible for award, prospective offerors must be registered in the System for Award Management (SAM) Internet site, www.sam.gov. For further information, please contact Yolanda Glover, Contract Specialist at [email protected].